Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of pennoside compound

A technology of pinanoside and compound, applied in the field of medicine

Pending Publication Date: 2021-07-30
SHAANXI UNIV OF CHINESE MEDICINE
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the therapeutic effect of pinanosides on the autoimmune disease rheumatoid arthritis has not been reported yet.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of pennoside compound
  • Application of pennoside compound
  • Application of pennoside compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0036] The present invention is further described below by examples, but the present invention is not limited by these examples. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included within the protection scope of the present invention.

[0037] The invention provides a pinanoside compound having a structure of formula (1) and the application of a pharmaceutically acceptable salt thereof in the preparation of a medicine for treating rheumatoid arthritis;

[0038]

[0039] Wherein, R is H or a sugar chain.

[0040] The pinenoside compound can be Paris saponin VII or Pennogenin 3β-O-α-L-rhamnopyranosyl-(1→4)-[-O-α-L-rhamnopyranosyl-(1→2)]-O-β- D-glucopyranoside can also be Paris saponin VI.

[0041] The pinanoside compound can reduce the proliferation of RA-FLS and MH7A synoviocytes, and trigger the apoptosis of RA-FLS and MH7A synoviocytes, and can be used to prepare drugs for reducing th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines, and particularly discloses application of a pennoside compound and pharmaceutically acceptable salt thereof in preparation of medicines for treating rheumatoid arthritis. In-vivo and in-vitro researches show that the pennoside compound PSVII acts on RA synovial cells to inhibit the proliferation of RA-FLS and MH7A and induce the apoptosis of the RA-FLS and MH7A. The compound can reduce the levels of serum TNF-alpha, IL-6 and IL-1beta, improve inflammatory cell infiltration, synovial hyperplasia and arthritis pathological changes of cartilage and bone erosion, relieve toe swelling, reduce the degree of ankle joint diameter swelling, and down-regulate the arthritis, thymus and spleen indexes The pennoside compound can be used for preparing medicines for treating rheumatoid arthritis.

Description

technical field [0001] The invention belongs to the technical field of medicine, and specifically discloses the application of a pinanoside compound; more specifically, it relates to the application of a pinanoside compound in preparing a medicine for treating rheumatoid arthritis. Background technique [0002] Rheumatoid arthritis (RA) is a known chronic autoimmune disease that can cause joint deformities and even loss of joint function. The pathogenesis of RA is complex, and its main pathological features mainly involve synovial hyperplasia, inflammatory cell infiltration, pannus formation, cartilage erosion and bone destruction. Although there are many different types of cells involved in the pathological process of RA, RA-FLS (RA fibroblast-like synoviocytes) are considered to play a key role in the initiation and driving of the pathological process of RA. [0003] In RA patients, the proliferation of FLS is not controlled by the body system, and activated FLS has the c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/58A61K31/7048A61P19/02A61P19/08A61P29/00
CPCA61K31/58A61K31/7048A61P19/02A61P19/08A61P29/00
Inventor 岳正刚周瑞何懿菡唐志书史励科
Owner SHAANXI UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com